Status:
COMPLETED
Vitamin C to Reduce Morning Cardiovascular Risk
Lead Sponsor:
Oregon Health and Science University
Conditions:
Cardiovascular Risk Factor
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
This study will test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participants will als...
Detailed Description
The investigators plan to test the efficacy of Vitamin C to counteract morning cardiovascular (CV) risk markers in a randomized, double blind, placebo controlled crossover pilot study. The participant...
Eligibility Criteria
Inclusion
- Healthy participants
- Normal weight or overweight but not obese (18.5\<BMI\<33 kg/m2)
Exclusion
- History of smoking/tobacco use
- Current prescription/non-prescription medications or drugs of abuse
- Acute, chronic, or debilitating medical conditions
- History of working irregular day and night hours, regular night work, or rotating shift work for the six months prior to the study.
Key Trial Info
Start Date :
February 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03290612
Start Date
February 13 2018
End Date
March 1 2022
Last Update
March 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239